Zura Bio Ltd
ZURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855644
No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Zura Bio Ltd as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +3 vs. Q2 2023
- Shares held
- 14.1M
- +1.30M (+10.1%) vs. Q2 2023
- Total value
- $93.3M
- −$11.7M (−11.1%) vs. Q2 2023
- New holders
- 7
- 21 more added
- Sold out
- 4
- 4 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 95 | $428.9M |
| Q1 2026 | 94 | $391.8M |
| Q4 2025 | 75 | $235.1M |
| Q3 2025 | 69 | $179.2M |
| Q2 2025 | 65 | $37.1M |
| Q1 2025 | 74 | $59.0M |
| Q4 2024 | 87 | $107.2M |
| Q3 2024 | 78 | $151.1M |
| Q2 2024 | 57 | $114.9M |
| Q1 2024 | 45 | $37.6M |
| Q4 2023 | 44 | $70.7M |
| Q3 2023 | 41 | $93.3M |
| Q2 2023 | 38 | $105.0M |
| Q1 2023 | 3 | $24.7K |
| Q4 2022 | 35 | $87.4M |
| Q3 2022 | 33 | $84.2M |
| Q2 2022 | 36 | $77.7M |
| Q1 2022 | 34 | $58.1M |
| Q4 2021 | 25 | $48.5M |
| Q3 2021 | 17 | $31.6M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Zura Bio Ltd; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 6 | $39 | 0.00% | −2,252−99.7% | Reduced |
| Russell Investments Group, Ltd. | 35 | $231 | 0.00% | +35 | New |
| IFP Advisors, Inc | 500 | $3.30K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 626 | $4.13K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 665 | $4.39K | 0.00% | +382+135.0% | Added |
| Amalgamated Bank | 738 | $5.00K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 1,600 | $10.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,758 | $11.6K | 0.00% | +486+38.2% | Added |
| Barclays PLC | 2,205 | $14.6K | 0.00% | +696+46.1% | Added |
| California State Teachers Retirement System | 2,617 | $17.3K | 0.00% | +95+3.8% | Added |
| Wells Fargo & Company | 2,931 | $19.3K | 0.00% | +21+0.7% | Added |
| American International Group, Inc. | 5,919 | $39.1K | 0.00% | +2,270+62.2% | Added |
| JPMorgan Chase & Co | 7,819 | $51.6K | 0.00% | +1,776+29.4% | Added |
| New York State Common Retirement Fund | 8,525 | $56.3K | 0.00% | +125+1.5% | Added |
| Lynx1 Capital Management LP | 9,917 | $65.5K | 0.04% | +9,917 | New |
| Rhumbline Advisers | 11,199 | $73.9K | 0.00% | +3,089+38.1% | Added |
| Forefront Analytics, LLC | 14,464 | $95.5K | 0.05% | +14,464 | New |
| Morgan Stanley | 17,083 | $112.7K | 0.00% | +11,657+214.8% | Added |
| Goldman Sachs Group Inc | 17,456 | $115.2K | 0.00% | +17,456 | New |
| Point72 Asset Management, L.P. | 21,100 | $139.3K | 0.00% | −448,177−95.5% | Reduced |
| Bank of America Corp | 23,530 | $155.3K | 0.00% | +15,423+190.2% | Added |
| Alliancebernstein L.P. | 25,090 | $165.6K | 0.00% | +1,690+7.2% | Added |
| Bank of New York Mellon Corp | 33,973 | $224.2K | 0.00% | +33,973 | New |
| Raymond James & Associates | 77,356 | $510.6K | 0.00% | +9,481+14.0% | Added |
| Charles Schwab Investment Management Inc | 96,097 | $634.2K | 0.00% | +23,172+31.8% | Added |
| Northern Trust Corp | 96,182 | $634.8K | 0.00% | +26,319+37.7% | Added |
| Eisler Capital (US) LLC | 100,000 | $660.0K | 0.24% | +100,000 | New |
| Invesco Ltd. | 118,158 | $779.8K | 0.00% | +59,049+99.9% | Added |
| State Street Corp | 161,308 | $1.06M | 0.00% | −4,556−2.7% | Reduced |
| UBS Oconnor LLC | 167,167 | $1.10M | 0.02% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 240,000 | $1.58M | 0.66% | 00.0% | Unchanged |
| Vanguard Group Inc | 243,329 | $1.61M | 0.00% | +14,977+6.6% | Added |
| Geode Capital Management, LLC | 262,920 | $1.74M | 0.00% | +62,321+31.1% | Added |
| Silverarc Capital Management, LLC | 404,040 | $2.67M | 0.99% | +244,040+152.5% | Added |
| Logos Global Management LP | 424,000 | $2.80M | 0.40% | +424,000 | New |
| BlackRock Inc. | 579,496 | $3.82M | 0.00% | +173,366+42.7% | Added |
| Citadel Advisors LLC | 712,500 | $4.70M | 0.01% | −405−0.1% | Reduced |
| Armistice Capital, LLC | 1,580,000 | $10.4M | 0.31% | +630,000+66.3% | Added |
| Deep Track Capital, LP | 2,523,000 | $16.7M | 0.65% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 2,850,000 | $18.8M | 1.02% | 00.0% | Unchanged |
| Great Point Partners LLC | 3,295,000 | $21.7M | 4.09% | 00.0% | Unchanged |
| Eisler Capital (UK) Ltd. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −17,250−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,162−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −1,087−100.0% | Sold out |